Clinical trial
Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour…
NCT05701241 · University Hospital, Antwerp, Other · Recruiting
Key facts
| NCT number | NCT05701241 |
|---|---|
| Title | Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients |
| Official title | Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients - The SAUNA Trial |
| Acronym | SAUNA |
| Lead sponsor | University Hospital, Antwerp, Other |
| Collaborators | Erasmus Medical Center ZonMw: The Netherlands Organisation for Health Research and Development Belgium Health Care Knowledge Centre |
| Status | Recruiting |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Gastroenteropancreatic Neuroendocrine Tumor |
| Intervention type | Drug |
| Interventions | Somatostatin analog |
| Enrollment | 270 |
| Start date | Jun 28, 2023 |
| Primary completion | Apr 1, 2029 |
| Completion | Apr 1, 2034 |
| First posted | Jan 27, 2023 |
| Last update posted | Jun 14, 2024 |
| Countries | Belgium, Netherlands |
At a glance
- 10–99 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: